In recent years, osteoporosis treatment has mainly comprised antiresorptive drugs (bisphosphonates, strontium salts) and bone anabolic compounds [parathyroid hormone peptides PTH (1-84 or 1-34)] (Kroupova et al., 2023). This evidence concerns the gene PTH and osteoporosis.